Ajanta Pharma promoter releases pledge on 98,185 shares for loan repayment
- Promoter Aayush Agrawal released pledge on 98,185 equity shares of Ajanta Pharma
- The release was undertaken for the purpose of loan repayment
- Post-event encumbered holding for the promoter stands at 9.32% of total share capital
- Aditya Birla Capital Ltd was the entity in whose favor the shares were originally pledged
*this image is generated using AI for illustrative purposes only.
Ajanta Pharma Limited promoter Aayush Agrawal, acting as trustee of the Aayush Agrawal Trust, has released a pledge on 98,185 equity shares of the company. The release, reported to stock exchanges on September 28, 2026, was executed to facilitate loan repayment obligations.
The disclosure was made under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction involved the gradual release of pledged shares held with Aditya Birla Capital Ltd across three dates in late September 2026.
Breakdown of pledge release events
The promoter’s holding in Ajanta Pharma stands at 1,41,12,924 shares, representing 11.29% of the total share capital. Prior to these releases, 1,17,40,571 shares (9.40%) were already encumbered. The recent activity reduced this encumbered portion through three distinct tranches.
| Date | Event Type | Shares Released | Post-Event Encumbered Shares | Post-Event Encumbered % |
|---|---|---|---|---|
| Sep 21, 2026 | Pledge Release | 55,500 | 1,16,85,071 | 9.35% |
| Sep 22, 2026 | Pledge Release | 18,518 | 1,16,66,553 | 9.34% |
| Sep 23, 2026 | Pledge Release | 24,167 | 1,16,42,386 | 9.32% |
The total number of shares released amounts to 98,185. Consequently, the post-event holding of encumbered shares for Aayush M Agrawal (Trustee) is now 1,16,42,386 shares, which constitutes 9.32% of the company's total share capital.
Other promoter holdings
The filing also detailed the status of other promoters and persons acting in concert (PAC). While several entities hold significant stakes, no new encumbrances or releases were reported for them during this specific disclosure period.
- Gabs Investments Pvt Ltd: Holds 1,25,88,393 shares (10.07%), with 27,70,000 shares (2.22%) currently encumbered.
- Yogesh M Agrawal (Trustee): Holds 1,80,78,147 shares (14.47%), with no shares encumbered.
- Rajesh M Agrawal (Trustee): Holds 1,80,78,148 shares (14.47%), with no shares encumbered.
- Ravi P Agrawal (Trustee): Holds 1,27,92,904 shares (10.24%), with 14,73,390 shares (1.18%) currently encumbered.
- Ganga Exports: Holds 33,48,261 shares (2.68%), with no shares encumbered.
What the numbers show
The reduction in Aayush Agrawal’s pledged shareholding from 9.40% to 9.32% indicates a marginal deleveraging of his personal stake. Despite this release, a substantial portion of his holding remains encumbered, accounting for approximately 82.5% of his total personal shareholding in the company. This high ratio of pledged-to-held shares suggests that while debt is being serviced, the promoter maintains a significant leverage position relative to his equity stake.
Historical Stock Returns for Ajanta Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.07% | -0.38% | -0.13% | +23.28% | +42.61% | 0.0% |
Will the continued high pledge ratio of 82.5% for Aayush Agrawal’s stake trigger any regulatory scrutiny or rating downgrades from credit agencies?
How might the gradual deleveraging by the Agrawal family influence institutional investor sentiment regarding Ajanta Pharma's governance stability in the upcoming quarters?
Are there plans for further share releases or new borrowings by other promoter entities like Gabs Investments Pvt Ltd to optimize their current encumbrance levels?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
